32 With a mean TNSS difference between Tacrosolv and placebo of 0.83 units ( p =0.061) on day 1 and 0.76 units ( p =0.034) on day 8, we see a clear trend towards a clinically important difference.
← all excerpts
Alleviation of Allergic Rhinoconjunctivitis Symptoms in Participants Treated with a 0.005% Tacrolimus Eye-Drop Solution.
2
—
—
The sentences
Even though the difference between active treatment and placebo was not statistically significant on either day, it showed a trend towards improvement over time.